Stephen Schondelmeyer
|
|
Stephen W. Schondelmeyer, Pharm.D., Ph.D.
Head of the Dept. of Pharmaceutical Care & Health Systems Professor of Pharmaceutical Economics Century Mortar Club Endowed Chair in Pharmaceutical Management
Office:
Telephone Number:
Fax Number:
E-mail Address:
|
Biography
Education
He received a B.S. in Pharmacy, University of Missouri; a Pharm.D., University of Kentucky; a Masters in Public Administration, Ohio State University; and a Ph. D. in Pharmaceutical Administration, Ohio State University.
Research Interests
Dr. Schondelmeyer has conducted policy analysis related to reimbursement of prescription drugs under Medicaid, Medicare, managed care and other third-party programs. He has been Commisioner of the Prescription Drug Payment Review Commission and served in an advisory capacity to Congress for the now-repealed Medicaid outpatient drug program. He has conducted research projects for a variety of sponsors, including the Health Care Financing Administration, the U.S. General Accounting Office, the Congressional Office of Technology Assessment, the U.S. Senate Special Committee on Aging, the U.S. Food and Drug Administration, the pharmaceutical industry and pharmaceutical associations. He has also conducted research for governments, organizations and associations of more than 30 countries, including Argentina, Canada, France, South Africa, South Korea, Spain, the United Kingdom and Venezuela.
Publications
Stephen W. Schondelmeyer has published many papers and is frequently called upon for invited presentations. His research has been widely quoted in the scientific, policy and public press. Quotes and citations have included: Time, U.S. News & World Report, Fortune, Forbes, The Wall Street Journal, The New York Times, The Pink Sheet, American Pharmacy, American Druggist, New England Journal of Medicine and Pharmaceutical Executive.
- Schondelmeyer SW. Competition and Pricing in the Pharmaceutical Market. Minneapolis: PRIME Institute, University of Minnesota, August 1994, 13 pp.
- Schondelmeyer SW, Wright G, Cherlow A, Johnson J, Suh DC, Impact of the Medicaid Drug Rebate Program, Health Care Financing Administration, Extramural Research Report, U.S. Department of Health and Human Services, Aug. 1995, 43 pp.
- Schondelmeyer SW. "Whatever Happened to Competition in the Marketplace?", Chapter One, 1996 Drug Outcomes Sourcebook (New York: Faulkner & Gray, 1995), pp. 23-26. (Reprinted from newsletter Drug Outcomes & Managed Care.)
- Schondelmeyer SW. "Uses of Pharmacoeconomic Data by Policy Makers and Pharmaceutical Benefit Managers," Chapter120 in Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edition, Bert Spilker, editor (Philadelphia, Lippincott-Raven Publishers, 1996), pp. 1153-1164.
- Cook DJ., Hoyt DB, Moore FA, Schondelmeyer SW. "Evidence-Based Medicine: The Critical Assessment of Data," Journal of Critical Care Nutrition, Vol 4, No 1, 1997, pp. 4-12.
- Schondelmeyer SW. The NACDS PRIME Index: Tracking Changes in Drug Prices. Minneapolis: PRIME Institute, University of Minnesota, February 1997, 10 pp.
- Schondelmeyer SW, Seoane-Vazquez EC. Pharmacists are working harder. American Druggist. 214(Aug): p 34-39. 1997.
- Suh DC, Schondelmeyer SW, Manning WG, Hadsall RS. Nyman, JA. Price trends before and after patent expiration in the pharmaceutical industry. Journal of Research in Pharmaceutical Economics. 9(2): p 17-32. 1998.
- Schondelmeyer SW. Patent Extension of Pipeline Drugs Impact on U.S. Health Care Expenditures. Minneapolis: PRIME Institute, University of Minnesota, 28 July 1999.